A Review on Novel Ligand Targeted Delivery for Cardiovascular Disorder.

Jaiswal, Shweta; Rajnikanth, P S; Thakur, Sunita; Deepak, Payal; Anand, Sneha

Jaiswal, Shweta; Rajnikanth, P S; Thakur, Sunita; Deepak, Payal; Anand, Sneha.

Afiliación

Jaiswal S; Department of Pharmaceutical Sciences, Babasaheb Bhimrao Ambedkar University, Lucknow, Uttar Pradesh, India.
Rajnikanth PS; Department of Pharmaceutical Sciences, Babasaheb Bhimrao Ambedkar University, Lucknow, Uttar Pradesh, India.
Thakur S; Department of Pharmaceutical Sciences, Babasaheb Bhimrao Ambedkar University, Lucknow, Uttar Pradesh, India.
Deepak P; Department of Pharmaceutical Sciences, Babasaheb Bhimrao Ambedkar University, Lucknow, Uttar Pradesh, India.
Anand S; Department of Pharmaceutical Sciences, Babasaheb Bhimrao Ambedkar University, Lucknow, Uttar Pradesh, India.

Curr Drug Deliv ; 18(8): 1094-1104, 2021.

Article en En | MEDLINE | ID: mdl-33645481

Asunto(s)

Enfermedades Cardiovasculares; Hipertensión; Hormonas Peptídicas; Receptores de Apelina; Enfermedades Cardiovasculares/tratamiento farmacológico; Humanos; Ligandos

Palabras clave

Cardiovascular disease; adropin; annexin-v; apelin; elabela.; ligand targeted therapy

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Enfermedades Cardiovasculares / Hormonas Peptídicas / Hipertensión Límite: Humans Idioma: En Revista: Curr Drug Deliv Asunto de la revista: FARMACIA / FARMACOLOGIA / TERAPIA POR MEDICAMENTOS Año: 2021 Tipo del documento: Article País de afiliación: India Pais de publicación: Emiratos Árabes Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google